title: Pharma pumps up anti-tau Alzheimer pipeline despite first Phase III failure.
authors: Asher
authors: A
authors: Mullard
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy*; D017326:Clinical Trials, Phase III as Topic; D004345:Drug Industry / Q000191:economics / Q000639:trends*; D006801:Humans; D016875:tau Proteins / Q000037:antagonists & inhibitors*
chemical_list: D016875:tau Proteins